AVEO Oncology to Present at the Jefferies Global Healthcare Conference

Press Release

View printer-friendly version

<<  Back

AVEO Oncology to Present at the Jefferies Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 28, 2014-- AVEO Oncology (NASDAQ:AVEO) today announced that Tuan Ha-Ngoc, chief executive officer, is scheduled to present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2014 at 8:30AM (ET) in New York City.

A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation.

About AVEO

AVEO Oncology (NASDAQ: AVEO) is a biopharmaceutical company committed to discovering and developing targeted therapies designed to provide substantial impact in the lives of people with cancer by addressing unmet medical needs. AVEO’s proprietary Human Response Platform™ provides the company with unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates. For more information, please visit the company’s website at www.aveooncology.com.

Source: AVEO Oncology

AVEO Oncology
Rob Kloppenburg, 617-299-5992